Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

CHAPEL HILL, N.C.--(BUSINESS WIRE)--iOrganBio today announced its launch from stealth with $2 million in funding to transform how human cells are made. The round was led by First Star Ventures along ...

AMSBIO (Oxford, UK) has launched GMP-grade StemFit ® for Differentiation, a chemically defined and animal component-free formulation that enables unmatched differentiation of human induced pluripotent ...

The use of stem cells as regenerative medicine is one of the most sought-after technologies for cell-based therapy required by many patients who need cell transplantations. 1 Stem cell research has ...